Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
FutureTech II Acquisition Corp.
futuretechii.comAI Executive Summary
AI-powered analysis of 8-K filing content
FutureTech II Acquisition Corp. engaged D. Boral Capital as its sole financial advisor for the De-SPAC merger with Longevity Biomedical, Inc., signaling acceleration of the business combination process initially announced in February 2025.
Key Takeaways
D. Boral Capital appointed as exclusive financial advisor for the Longevity Biomedical merger, indicating active progression toward deal closure
Engagement letter executed on March 4, 2026, demonstrates urgency in finalizing the SPAC combination after initial S-4 filing in February 2025
2 more takeaways